// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Byron L Lam - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

The audibility of low vision devices with speech output used by older adults with sensory impairment

Lorie St-Amour - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Calibration of the Impact of Vision Impairment Instrument (IVI) Questionnaire

Judith Goldstein - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Is Compliance and Ocular Surface Factors Associated with Contact Lens Dropout?

Andrew David Pucker - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Novel therapeutic strategies to rescue the developmental abnormalities in aniridic glaucoma

Vahitha Shameem Nizamudheen - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Ataluren

Profiling the regulatory networks controlling early steps of phagocytosis in the retinal pigmented epithelium

Aleksander Tworak - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Relative Ability of Optical Coherence Tomography (OCT) Structural Parameters to Detect Structural Abnormality in Glaucoma Suspect and Glaucoma Eyes

Hongli Yang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Unmet Eye Care Needs Among a Syrian Pediatric Refugee Population

myrna lichter - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The prevalence and determinants of visual impairment in Canada: Cross-sectional data from the Canadian Longitudinal Study on Aging

Ellen E Freeman - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Suppression rather than visual acuity loss limits threshold stereoacuity.

Ann Louise Webber - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Brief Retinal Inactivation Promotes Recovery From Long-Term Monocular Deprivation

Kevin Duffy - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

carisoprodol

Altered white matter structure within the visual pathway of children with early unilateral enucleation

Arijit Chakraborty - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Canadian Ophthalmic Practitioners Ergonomics (COPE) Study

Femida Kherani - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Parental Decision-Making Processes in Pediatric Trial Enrollment: Recommendations for Informed Consent in Genetic Eye Disease Research for Cell Therapies

Stephanie Brooks - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Burden, timing, and outcomes of uveitis from a retrospective cohort of Ebola survivors in Sierra Leone

Matthew Jusu Vandy - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Syphilitic Uveitis as the Presenting Manifestation of Syphilis at a Canadian Tertiary Care Centre

Harrish Nithianandan - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Reagin

Impact of unrestricted postoperative head positioning on outcomes of pars plana vitrectomy for primary rhegmatogenous retinal detachment repair.

Mohamed K Soliman - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Advantages of endoscopy-assisted vitrectomy for silicone oil removal in complex retinal detachments

Natalia Vila - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Surgical Success and Functional Outcomes of Failed Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment

Zaid Mammo - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

MACULAR HOLE AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR

Rayan Alshareef - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved